News search

The study, published in Nature, provides information with important implications for mitochondrial donation therapies, which produce children with three genetic parents

The study, published in Nature Immunology, opens the way to the possible use of CD69 as a therapeutic target for the control of this disease

CNIC scientists reveal how changes in the metabolism of mitochondria allow the cells of the immune system to adapt to living or dead bacteria

Half of patients with CVD show no above-normal risk of developing the disease on the basis of classical risk factors, such as high cholesterol, smoking, lack of exercise, and high blood pressure

The results could form the basis for the development of future interventions in certain heart conditions and myopathies

These genes form part of a signaling mechanism that is possibly altered in patients with a bicuspid aortic valve (BAV), a prevalent condition that compromises cardiovascular health

The protein Aurora A controls the initial phases of T lymphocyte activation

Investigadores del Instituto Aragonés de Ciencias de la Salud (IACS) de Zaragoza y del Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) de Madrid han descrito un método para el diagnóstico precoz de la arteriosclerosis.